Why Peptides Matter Now
From insulin to GLP-1s — and why peptides became one of medicine's fastest-moving frontiers.
What's covered
Click any topic to expand a deeper drill-down with mechanism, key references, and a take-home summary.
By the end of this module you will be able to
- L01Define a therapeutic peptide and distinguish it from small-molecule drugs and biologic proteins.
- L02Name three FDA-approved peptide therapeutics from different drug classes.
- L03Explain the regulatory difference between an FDA-approved peptide, a 503A compounded peptide, and an unregulated 'research peptide'.
- L04Apply a critical-appraisal checklist to a peptide claim from a clinic, podcast, or supplement seller.
What you should walk away believing
Click any takeaway to open a full AI-generated lesson with mechanism, examples, evidence grading, counseling scripts, pearls, references, and a self-check.
What this means for you
Peptides are short chains of amino acids that act as signaling molecules. Some — like insulin and GLP-1 medications (Ozempic, Wegovy, Mounjaro) — are tightly regulated, well-studied prescription drugs. Many others sold online or by 'wellness clinics' are not approved and have very little human evidence. This course teaches you how to tell them apart.
Frame peptides as a heterogeneous drug class spanning replacement hormones (insulin, glucagon, ADH), receptor agonists/antagonists (GLP-1 RAs, octreotide, leuprolide, oxytocin), and an expanding investigational space (BPC-157, TB-500, GHK-Cu, MOTS-c, epitalon). The line between 'approved drug' and 'research chemical' is regulatory, not chemical — emphasize this when patients ask about clinic-prescribed peptides.
Position the field within the 2017–2025 surge: tirzepatide (dual GIP/GLP-1), retatrutide (triagonist), survodutide (GLP-1/glucagon), and the post-Ozempic wave of cardiometabolic, MASH, and renal indications. Track parallel concerns about compounded semaglutide/tirzepatide (FDA shortage list dynamics) and the 'longevity peptide' market.
Peptides are a natural, gentler alternative to drugs.
Insulin is a peptide. So is leuprolide, calcitonin, and semaglutide. 'Peptide' is a chemical class, not a safety category. Some peptides are among medicine's most powerful — and most dangerous — molecules.
What the data say
Test yourself
Lock it in — review what's due
Key terms & abbreviations
- Peptide
- Short amino-acid chain (typically 2–50 residues) joined by peptide bonds.
- GLP-1 receptor agonistGLP-1 RA
- Class of incretin-mimetic peptides that bind the GLP-1 receptor; includes semaglutide, liraglutide, dulaglutide, exenatide.
- Compounding pharmacy
- State-licensed pharmacy preparing custom medications under FDA 503A (patient-specific) or 503B (outsourcing facility) rules.
- 503A vs 503B
- 503A: patient-specific compounding by a licensed pharmacy. 503B: registered outsourcing facility producing larger batches under cGMP-like standards.
- APIActive Pharmaceutical Ingredient
- The actual drug molecule. For peptides, source country, salt form, and purity testing vary widely outside FDA-approved products.
- Research-only peptide
- Marketing label used to sell unapproved peptides while disclaiming therapeutic intent. Not a regulatory category — and not legal protection if the product is administered to humans.
Optional deeper dive
- Therapeutic peptides: current applications and future directions — Wang et al., Sig Transduct Target Ther 2022
- FDA Statement on Compounded GLP-1 Products — U.S. FDA, 2024
Sources cited in this module
- [1]Medications containing semaglutide marketed for type 2 diabetes or weight lossU.S. FDA Drug Safety Communication · 2024Regulatory · T1
- [2]Therapeutic peptides: current applications and future directionsWang L. et al. · Signal Transduction and Targeted Therapy · 2022Review · T2
- [3]Pancreatic extracts in the treatment of diabetes mellitusBanting FG, Best CH, Collip JB, Campbell WR, Fletcher AA · Canadian Medical Association Journal · 1922Case series · T3